Home » Stocks » LNSR

LENSAR, Inc. (LNSR)

Stock Price: $6.46 USD 0.06 (0.94%)
Updated Jan 22, 2021 1:12 PM EST - Market open
Market Cap 69.15M
Revenue (ttm) 26.56M
Net Income (ttm) -15.41M
Shares Out 7.46M
EPS (ttm) -2.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $6.46
Previous Close $6.40
Change ($) 0.06
Change (%) 0.94%
Day's Open 6.32
Day's Range 6.32 - 6.58
Day's Volume 9,248
52-Week Range 6.28 - 12.20

News

There are no news available yet.

About LNSR

LENSAR operates as a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Industry
Medical Devices
CEO
Nicholas T. Curtis
Employees
75
Stock Exchange
NASDAQ
Ticker Symbol
LNSR
Full Company Profile

Financial Performance

In 2019, LENSAR, Inc's revenue was $30.53 million, an increase of 25.18% compared to the previous year's $24.39 million. Losses were -$14.66 million, 16.4% more than in 2018.

Financial Statements